TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 45th Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on […]
Total revenue grew 54% and net interest income increased 12% over prior year quarter Successful completion and systems conversion of Penns Woods merger Strong 2Q net interest margin at 3.56% as we continue to manage our funding costs and maintain our loan yield Noninterest income grew 9% over prior quarter 2Q25 adjusted (non-GAAP) net income
Landstar System Reports Second Quarter Revenue of $1.211b and Earnings Per Share of $1.20 GlobeNewswire July 29, 2025 JACKSONVILLE, Fla., July 29, 2025 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic and diluted earnings per share (“EPS”) of $1.20 in the 2025 second quarter on revenue of $1.211
Sera PrognosticsInc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report second quarter fiscal year 2025 financial results on Wednesday, August 6, 2025, after the close of the market. The Company will host a corresponding conference
Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, will release its second quarter 2025 financial results on Tuesday, August 12, 2025, after market close. Todd DeBonis, President and CEO, and Haley Aman, CFO, will host a conference call at 2:00 p.m. Pacific Time to discuss the Company's financial results.
Net Loss Exceeded Expectations; Adjusted EBITDA Margin Improved 120 Basis Points versus Last Year Strong Rejuvenate 2.0 Demand More than Double the Rejuvenate 1.0 Launch inDTC Mattress Firm Rollout Progressing on Schedule Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company whose mattresses promise to give you “less pain, better sleep,” today announced results
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”), have until Tuesday, August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. CaptionedShouse v. Tempus
Mercury General Corporation (NYSE:MCY) reported today for the second quarter of 2025: Consolidated Highlights Three Months Ended June 30, Change Six Months Ended June 30, Change 2025 2024 $ % 2025 2024 $ %(000's except per-share amounts and ratios)Net premiums earned (2) $ 1,366,738 $ 1,236,024 $ 130,714 10.6 $ 2,649,808 $ 2,402,703 $ 247,105
MondelĔz International Reports Q2 2025 Results GlobeNewswire July 29, 2025 Second Quarter Highlights1 Net Revenues +7.7%, Organic Net Revenues +5.6%, Volume/Mix -1.5% Diluted EPS increased 8.9% to $0.49Adjusted EPS was $0.73 which declined 14.5% on a constant currency basis Year-to-date cash provided by operating activities was $1.4 billionand Free Cash Flow was $0.8 billionReturn of
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its second quarter 2025 financial results and providea Company update after the market closes on Tuesday, August 5, 2025. https://mma.prnewswire.com/media/84325/Cumberland_Pharmaceuticals_logo_new1.jpg A conference call will be held on August 5 at 4:30 p.m. Eastern Time to discuss the results and update.